405 related articles for article (PubMed ID: 2785367)
1. Reflection of disease activity in rheumatoid arthritis by indices of activation of the classical complement pathway.
Makinde VA; Senaldi G; Jawad AS; Berry H; Vergani D
Ann Rheum Dis; 1989 Apr; 48(4):302-6. PubMed ID: 2785367
[TBL] [Abstract][Full Text] [Related]
2. Correlation of the activation of the fourth component of complement (C4) with disease activity in systemic lupus erythematosus.
Senaldi G; Makinde VA; Vergani D; Isenberg DA
Ann Rheum Dis; 1988 Nov; 47(11):913-7. PubMed ID: 3264693
[TBL] [Abstract][Full Text] [Related]
3. Activation of classical pathway complement in chronic inflammation. Elevated levels of circulating C3d and C4d split products in rheumatoid arthritis and Crohn's disease.
Petersen NE; Elmgreen J; Teisner B; Svehag SE
Acta Med Scand; 1988; 223(6):557-60. PubMed ID: 3389208
[TBL] [Abstract][Full Text] [Related]
4. Sensitivity and specificity of plasma and urine complement split products as indicators of lupus disease activity.
Manzi S; Rairie JE; Carpenter AB; Kelly RH; Jagarlapudi SP; Sereika SM; Medsger TA; Ramsey-Goldman R
Arthritis Rheum; 1996 Jul; 39(7):1178-88. PubMed ID: 8670328
[TBL] [Abstract][Full Text] [Related]
5. Activation of the complement system in human immunodeficiency virus infection: relevance of the classical pathway to pathogenesis and disease severity.
Senaldi G; Peakman M; McManus T; Davies ET; Tee DE; Vergani D
J Infect Dis; 1990 Dec; 162(6):1227-32. PubMed ID: 1977807
[TBL] [Abstract][Full Text] [Related]
6. Different patterns of C3 and C4 activation in the varied types of juvenile arthritis.
Miller JJ; Olds LC; Silverman ED; Milgrom H; Curd JG
Pediatr Res; 1986 Dec; 20(12):1332-7. PubMed ID: 3099253
[TBL] [Abstract][Full Text] [Related]
7. Complexes between C1q and C3 or C4: novel and specific markers for classical complement pathway activation.
Wouters D; Wiessenberg HD; Hart M; Bruins P; Voskuyl A; Daha MR; Hack CE
J Immunol Methods; 2005 Mar; 298(1-2):35-45. PubMed ID: 15847795
[TBL] [Abstract][Full Text] [Related]
8. Complement activation by cellulosic dialysis membranes.
Innes A; Farrell AM; Burden RP; Morgan AG; Powell RJ
J Clin Pathol; 1994 Feb; 47(2):155-8. PubMed ID: 8132830
[TBL] [Abstract][Full Text] [Related]
9. Complement activation products in idiopathic pulmonary fibrosis: relevance of fragment Ba to disease severity.
Meliconi R; Senaldi G; Sturani C; Galavotti V; Facchini A; Gasbarrini G; Vergani D
Clin Immunol Immunopathol; 1990 Oct; 57(1):64-73. PubMed ID: 2394036
[TBL] [Abstract][Full Text] [Related]
10. Complement activation in patients with rheumatoid arthritis mediated in part by C-reactive protein.
Molenaar ET; Voskuyl AE; Familian A; van Mierlo GJ; Dijkmans BA; Hack CE
Arthritis Rheum; 2001 May; 44(5):997-1002. PubMed ID: 11352263
[TBL] [Abstract][Full Text] [Related]
11. A novel ELISA for the assessment of classical pathway of complement activation in vivo by measurement of C4-C3 complexes.
Zwirner J; Dobos G; Götze O
J Immunol Methods; 1995 Oct; 186(1):55-63. PubMed ID: 7561148
[TBL] [Abstract][Full Text] [Related]
12. Activation of the complement system in primary sclerosing cholangitis.
Senaldi G; Donaldson PT; Magrin S; Farrant JM; Alexander GJ; Vergani D; Williams R
Gastroenterology; 1989 Dec; 97(6):1430-4. PubMed ID: 2583409
[TBL] [Abstract][Full Text] [Related]
13. Studies on the haemolytic activity of circulating C1q-C3/C4 complexes.
Wouters D; Brouwer MC; Daha MR; Hack CE
Mol Immunol; 2008 Apr; 45(7):1893-9. PubMed ID: 18054386
[TBL] [Abstract][Full Text] [Related]
14. Clinical application of new technique that measures C4d for assessment of activation of classical complement pathway.
Davies ET; Nasaruddin BA; Alhaq A; Senaldi G; Vergani D
J Clin Pathol; 1988 Feb; 41(2):143-7. PubMed ID: 3350977
[TBL] [Abstract][Full Text] [Related]
15. Complement activation before, during and after cardiopulmonary bypass.
Bonser RS; Dave JR; John L; Gademsetty MK; Carter PG; Davies E; Taylor P; Gaya H; Lennox SC; Vergani D
Eur J Cardiothorac Surg; 1990; 4(6):291-6. PubMed ID: 2361017
[TBL] [Abstract][Full Text] [Related]
16. [Serum complement levels in patients with rheumatoid arthritis and vasculitis].
Tomooka K
Fukuoka Igaku Zasshi; 1989 Oct; 80(10):456-66. PubMed ID: 2613159
[TBL] [Abstract][Full Text] [Related]
17. Classical complement activation induced by pregnancy: implications for management of connective tissue diseases.
Hopkinson ND; Powell RJ
J Clin Pathol; 1992 Jan; 45(1):66-7. PubMed ID: 1740520
[TBL] [Abstract][Full Text] [Related]
18. Activation of the complement system in systemic sclerosis. Relationship to clinical severity.
Senaldi G; Lupoli S; Vergani D; Black CM
Arthritis Rheum; 1989 Oct; 32(10):1262-7. PubMed ID: 2803327
[TBL] [Abstract][Full Text] [Related]
19. Monoclonal antibodies against complement 3 neoantigens for detection of immune complexes and complement activation. Relationship between immune complex levels, state of C3, and numbers of receptors for C3b.
Aguado MT; Lambris JD; Tsokos GC; Burger R; Bitter-Suermann D; Tamerius JD; Dixon FJ; Theofilopoulos AN
J Clin Invest; 1985 Oct; 76(4):1418-26. PubMed ID: 2932466
[TBL] [Abstract][Full Text] [Related]
20. Correlation in rheumatoid arthritis of concentrations of plasma C3d, serum rheumatoid factor, immune complexes and C-reactive protein with each other and with clinical features of disease activity.
Mallya RK; Vergani D; Tee DE; Bevis L; de Beer FC; Berry H; Hamilton ED; Mace BE; Pepys MB
Clin Exp Immunol; 1982 Jun; 48(3):747-53. PubMed ID: 6981476
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
